期刊文献+

左心室壁中层缩短率评价2型糖尿病患者早期左心室收缩功能变化 被引量:3

Assessment of Early Changes of Left Ventricular Systolic Function by Ventricular Midwall Fractional Shortening in Patients With Type 2 Diabetes Mellitus
下载PDF
导出
摘要 目的:运用左心室壁中层缩短率评价2型糖尿病患者早期左心室收缩功能改变。方法:51例2型糖尿病者(糖尿病组)及30例体验正常者(对照组),行常规及组织多普勒超声心动图检查,测量左心室壁中层缩短率(mFS),计算左心室经线及圆周收缩末期应力,对两组间左心室结构和收缩功能指标即mFS、左心室射血分数、左心室短轴缩短率(LVFS)和二尖瓣环收缩期峰值运动速度(Sm)进行比较,并对mFS与左心室结构参数、空腹血糖水平行相关分析。结果:糖尿病组与对照组比较,左心室舒张末径、左心室收缩末径、左心室质量、左心室心肌质量指数均增加(P<0.01),mFS减低[(21.9±3.4)%vs(24.2±2.6)%,P<0.01]。两组间舒张期室间隔厚度、舒张期左心室后壁厚度及相对室壁厚度比较,差异无统计学意义。mFS与左心室收缩末径、左心室质量、左心室心肌质量指数负相关(r值分别为-0.586、-0.332和-0.239,P<0.05),与空腹血糖水平亦呈负相关(r=-0.315,P=0.011),这种负相关在校正了年龄、性别、收缩压和体重指数的影响后仍然存在。结论:2型糖尿病患者存在亚临床的左心室收缩功能变化,室壁中层缩短率是检测糖尿病患者早期心肌收缩力下降的敏感指标。 Objective: To assess the early changes of left ventricular systolic function by ventricular midwall fractional shortening (mFS) in patients with type 2 diabetes mellitus (DM). Methods: Our study included two groups, DM group, n = 51 and Control group, n=30 volunteers without DM. Echocardio- graphy was performed in all participants to detect mFS, to calculate left ventricular circumferential end-systohc stress and to com- pare left ventricular ejection fraction (LVEF), left ventricular fractional shortening (LVFS), and mitral annular systolic velocity (Sin) between two groups. In addition, the correlations between mFS and the parameters of cardiac structure and fasting blood glu- cose (FBG) level were analyzed. Results: Compared with Control group, DM group had increased diameter of left ventricle, increased left ventricular mass (LVM) and left ventricular mass index (LVMI),P〈0. 01 respectively. DM group had lower mFS than that in Control group(21.9 ±3.4) % vs. (24. 2±2. 6)% ,P〈0. 01. There was no statistic difference for the relative thickness of ventricular wall between two groups, mFS was negatively correlated to left ventricular end-systolic diameter, LVM and LVMI(r=-0. 586, r=-0. 332 and r = -0. 239,P〈0. 05 respectively), mFS was negatively related to FBG ( r = -0. 315,P= 0.011 ). With the adjusted influence of age, gender, systolic blood pressure and body mass index, those negative correlations were still exist. Conclusion: Type 2 DM patients have sub-clinical left ventricular systolic functional changes, mFS is a sensitive parameter for assessing the early ventricular systolic dysfunction in DM patients.
出处 《中国循环杂志》 CSCD 北大核心 2011年第6期446-449,共4页 Chinese Circulation Journal
关键词 糖尿病 超声心动图 左心室收缩功能 左心室壁中层缩短率 Diabetes mellitus Echocardiography Left ventricle systolic function Midwall fractional shortening
  • 相关文献

参考文献11

  • 1Shimuzu G, Hirota Y, Kita Y, et al. Left ventricular midwall mechanics in systemic arterial hypertension, myocardial function is depressed in pressure-overload hypertrophy. Circulation, 1991,83 : 1676-1682.
  • 2de Simone G, Devereux RB, Roman M J, et al. Assessment of left ventricular ftmction by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol,1994,23 :1444-1451.
  • 3Voulgari C, Papadogiannis D, Tentolouris N. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytesto current diagnosis and managemen strategies. Vasc Health Risk Manag,2010, 6: 883 -903.
  • 4Ouwens DM, Diamant M. Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy. Arch Physiol Biochem,2007,113:76-86.
  • 5Dobrin JS, Lebeche D. Diabetic cardiomyopathy: signaling defects and therapeutic approaches. Expert Rev Cardiovasc Ther, 2010, 8: 373-391.
  • 6焦向英,王晓樑,马新亮,赵荣瑞.高糖高脂对培养成年小鼠心肌细胞的氧化应激损伤[J].中国循环杂志,2009,24(1):64-67. 被引量:9
  • 7de Simone G, Devereux RB. Rationale of Echocardiographic Assessment of Left Ventricular Wall Stress and Midwall Mechanics in Hypertensive Heart Disease. Eur J Echocardiog,2002,3 : 192-198.
  • 8Gaasch WH, Zile MR, Hoshino PK, et al. Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy. Circulation, 1989, 79:872-883.
  • 9Wachtell K, Gerdts E, Palmieri V, et al. In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function:the Losartan Intervention For Endpoint reduction study. J Hypertens ,2010,28 : 1541-1546.
  • 10李卫虹,冯新恒,李昭屏,冯杰莉,高炜.脉冲波组织多普勒超声心动图检测肥胖患者心脏结构和心功能[J].中国循环杂志,2010,25(4):295-298. 被引量:13

二级参考文献20

  • 1Geiss IS,Harris MI,Cowie CC,et al.Diabetes in America.National Institutes of Health,1995.
  • 2Cai L,Wang Y,Zhou G,et al.Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.J Am Coll Cardiol.2006,48(8):1688-1697.
  • 3Shen JJ,Chang LT,Chiang CH,et al.Impact of diabetes on cardiomyocyte apoptosis and connexin43 gap junction integrity:role of pharmacological modulation,Int Heart J,2007,48(2):233-245.
  • 4Sjoholm A,Nystrom T.Inflammation and the etiology of type 2 diabetes.Diabetes Metab Res Rev,2006,22(1):4-10.
  • 5Pacher P,Szab?C.Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes.Curr Opin Pharmacol,2006,6(2):136-141.
  • 6Tao L,Liu HR,Gao F,et al.Mechanical traumatic injury without circulatory shock causes cardiomyocyte apoptosis:role of reactive nitrogen and reactive oxygen species.Am J Physiol Heart Circ Physiol,2005,288(6):H2811-H2818.
  • 7Tao L,Liu HR,Gao E,et al.Antioxidative,antinitmtive,and vasculoprotective effects of a peroxisome proliferator-activated receptor-agonist in hypercholesterolemia.Circulation,2003,108 (22):2805-2811.
  • 8Berry C,Tardif JC,Bourassa MG.Coronary heart disease in patients with diabetes:part ?:recent advances in coronary revascularization.J Am Coll Cardiol,2007,49(6):643-656.
  • 9Ricci C,Jong CJ,Schaffer SW.Proapoptotic and antiapoptotic effects of hyperglycemia:role of insulin signaling.Can J Physiol Pharmacol,2008,86(4):166-172.
  • 10Andrea F,Jan K,Cristina C,et al.Myocardial Cell Death in Human Diabetes.Circulation Research,2000,87:1123-1132.

共引文献20

同被引文献20

  • 1张琪,杜宇,陈国广,李学明,应汉杰.小麦中提取的α-淀粉酶抑制剂调节血脂及抗动脉粥样硬化的实验研究[J].中国药科大学学报,2005,36(6):572-576. 被引量:20
  • 2路一平,邱健,詹纯列.实验性糖尿病动脉粥样硬化大鼠模型的建立[J].四川动物,2006,25(1):165-167. 被引量:13
  • 3Xu J,Zou MH.Molecular insights and therapeutic targets for diabetic endothelial dysfunction[J].Circulation,2009,120 (13):1266-1286.
  • 4Sitia S,Tomasoni L,Atzeni F,et al.From endothelial dysfunction to atherosclerosis[J].Autoimmun Rev,2010,9(12):830-834.
  • 5Mizuno Y,Jacob RF,Mason RP.Inflammation and the development of atherosclerosis[J].J Atheroscler Thromb,2011,18 (5):351-358.
  • 6Gojo A,Utsunomiya K,Taniguchi K,et al.The Rho-kinase inhibitor,fasudil,attenuates diabetic nephropathy in streptozotocin-induced diabetic rats[J].Eur J Pharmacol,2007,568 (1-3):242-247.
  • 7McGarry JD.Banting lecture 2001:dysregulation of fatty acid metabolism in the etiology of type 2 diabetes[J].Diabetes,2002,51 (1):7-18.
  • 8Kandabashi T,Shimokawa H,Miyata K,et al.Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta[J].Circulation,2000,101 (11):1319-1323.
  • 9Mallat Z,Gojova A,Sauzeau V,et al.Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice[J].Circ Res,2003,93(9):884-888.
  • 10Satoh S,Utsunomiya T,Tsurui K,et al.Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage[J].Life Sci,2001,69(12):1441-1453.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部